BeiGene | BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

⟵ Back to Search Results

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

Beigene Study ID

BGB-43395-101

ClinicalTrials.gov ID

NCT06120283

EudraCT Number

2023-506888-34-00

China Drug Trials ID

CTR20243370

Sex: All

Age: 18 Years / N/A

No Study Documents

Locations

Sex: All

Age: 18 Years / N/A

No Study Documents